Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
about
Progress in adjuvant chemotherapy for breast cancer: an overviewDifferential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxelDose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid CancerDose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trialOptimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling.Adjuvant therapy of breast cancer.Dose-dense chemotherapy for breast cancer.Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug development.Anti-angiogenic therapy versus dose-dense paclitaxel therapy for frontline treatment of epithelial ovarian cancer: review of phase III randomized clinical trials.Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF and weekly paclitaxel in patients with resected high-risk breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: a phase II study.Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation.Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer.Simulating the hallmarks of cancer.Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial
P2860
Q26798078-B2A52A25-429E-419C-BCDD-F9FA6A74DA0BQ28728830-6631D124-B167-4950-9D88-4F17208A7CEDQ33369478-BBF9BA5E-B4D1-4992-BA38-FCD632AB6075Q33373879-CE18DA99-5676-44AE-BD81-A8DA3F89BF86Q34043403-B7E37981-9872-4707-AD4C-D2EF43E7CFE1Q34468964-85DD434D-0B04-4414-8B45-91BB57708E2BQ35585064-1C9A7B60-D866-4428-B2F0-9ADBD53EA085Q36276364-99401063-AE4F-472D-B5B7-954A236D377BQ38009885-9CDA3900-580B-4A56-AFC2-D514CD990F27Q38013289-AF01FCA4-09FC-43FF-8281-33336B9B6267Q38257830-4DB5D021-09AA-4CCB-AE29-B35870B9B823Q39375196-BF9F663E-583C-4E19-B4B2-7AABD7315133Q46528079-DEF6980C-4C6E-4D89-8961-5A55ABFC099FQ46632083-AAAC6017-D997-4C30-81B0-650B11A9DCA9Q47138521-2AEDA561-4372-4989-9435-BD6271A84BBEQ49650228-56907738-CAA5-4181-BD74-271246A2226BQ51933982-F002F720-BFFA-4E27-B535-94904B10CD58Q57904482-82B72358-32B2-43AA-9EDC-96C77F4B6654
P2860
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
@ast
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
@en
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
@nl
type
label
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
@ast
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
@en
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
@nl
prefLabel
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
@ast
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
@en
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
@nl
P1433
P1476
Theoretical concepts and the emerging role of taxanes in adjuvant therapy.
@en
P356
10.1634/THEONCOLOGIST.6-SUPPL_3-30
P478
P50
P577
2001-01-01T00:00:00Z